Drug Shortage Report for APRESOLINE

Last updated on 2019-02-28 History
Report ID 58938
Drug Identification Number 00723754
Brand name APRESOLINE
Common or Proper name Hydralazine Hydrochloride for injection
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) HYDRALAZINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 vials
ATC code C02DB
ATC description ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-09-28
Actual start date
Estimated end date
Actual end date 2019-02-27
Shortage status Resolved
Updated date 2019-02-28
Company comments Product is on 125% allocation at McKesson.
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2019-02-28 English Compare
v20 2019-02-26 French Compare
v19 2019-02-26 English Compare
v18 2019-02-26 English Compare
v17 2018-12-12 French Compare
v16 2018-12-12 English Compare
v15 2018-12-12 English Compare
v14 2018-12-05 French Compare
v13 2018-12-05 English Compare
v12 2018-11-15 French Compare
v11 2018-11-15 English Compare
v10 2018-10-25 French Compare
v9 2018-10-25 English Compare
v8 2018-10-25 English Compare
v7 2018-10-25 French Compare
v6 2018-10-25 English Compare
v5 2018-09-27 French Compare
v4 2018-09-27 English Compare
v3 2018-08-25 English Compare
v2 2018-08-24 French Compare

Showing 1 to 20 of 21